CBLN1 and cancer: In the current work, a semi-quantitative analysis of 105 metabolites reveals significant differences in the faecal composition of cancer samples in the following lipids: PC(16:0/16:0), PC(32:1), PC(O-16:0/16:0), PE(16:0/18:1), PE(16:0/18:2), SM(d18:1/16:0), SM(d18:1/23:0), SM(d18:2/24:1) + SM(d18:1/24:0), SM(42:1), Cer(d18:1/16:0), Cer(d18:1/24:1) + Cer(d18:2/24:0), Cer(42:1), SM(42:3), ChoE(16:0), ChoE(18:1), ChoE(18:2), ChoE(20:4), TG(54:1).